Departing FTC Chair Lina Khan (Michael Brochstein/Sipa USA)(Sipa via AP Images)
FTC goes after pharma middlemen's price hikes on 'specialty' drugs
The top three pharmacy benefit managers hiked the prices of dozens of “specialty” generic drugs, some by more than 1,000% of their acquisition cost, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
